Somapacitan for treating growth hormone deficiency in people 3 to 17 years

  • Technology appraisal guidance
  • TA1066
  • Published: 

History

Final draft guidance

Declaration of interests

Invitation to participate

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6178